Revelation Biosciences reports FY results
Source: SeekingAlpha
2026-02-27 07:02:08 ET
More on Revelation Biosciences
- Seeking Alpha’s Quant Rating on Revelation Biosciences
- Historical earnings data for Revelation Biosciences
- Financial information for Revelation Biosciences
Read the full article on Seeking Alpha
For further details see:
Revelation Biosciences reports FY results
Revelation Biosciences Inc.
NASDAQ: REVB
REVB Trading
-1.79% G/L:
$1.21 Last:
28,483 Volume:
$1.22 Open:
REVB Latest News
February 26, 2026 04:15:00 pm
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
January 26, 2026 09:55:00 am
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
January 23, 2026 02:10:00 pm
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
January 21, 2026 08:30:00 am
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
REVB Stock Data
$4,144,526
2,412,219
14.03%
10
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
